Top news of the week: 18.07.2022.
Biotech employees cash in health care’s largest salaries, while people working at providers sit near the bottom
It pays to be in the lab. It pays way less to be at the patient’s bedside, according to a STAT analysis of the median pay for employees at more than 200 publicly traded health care ...
New data might have led to a different result for Amarin fish oil drug, FDA panelists say
Two members of an expert panel that recommended the FDA approve a fish-oil-based heart drug, Vascepa, said recently released data would have led them to reconsider their votes.
Health care’s high rollers: As the pandemic raged, CEOs’ earnings surged
Special Report: Health care’s top executives are cushioned more than ever by the rising fortunes of their stock ownership.
High-Tech Smell Sensors Aim to Sniff Out Disease, Explosives—and Even Moods
Advances in artificial intelligence, bioengineering and synthetic biology are powering a new breed of odor sensors, some using living cells.
FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts
The agency hopes the availability of a more traditional vaccine might help convince those skeptical of the Covid shots using new mRNA technology to get inoculated.
Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co. Research Report
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments.
Investors See Far Out Profits in Psychedelic Medicine
A former hedge-fund portfolio manager raises millions from scientists, financiers and crypto bros eager to buy into treatments that aren’t even legal yet.